Serum appearance of anti-p53 antibody in triple negative breast cancer

Tadahiro Nozoe, Emiko Mori, Mayuko Kono, Tomohiro Iguchi, Takashi Maeda, Akito Matsukuma, Takahiro Ezaki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Significance of serum appearance of anti-p53 antibody in breast cancer has not been discussed fully. Methods: The relationship between serum appearance of anti-p53 antibody and the clinicopathological features was investigated on the basis of the data of 42 women with breast cancer who had been treated with surgical resection. Results: The proportion of tumors with histological grade 3 was significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.020). The proportion of triple negative tumors was also significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.003). Conclusions: Preoperative appearance of anti-p53 antibody in sera can be correlated with the incidence of triple negative breast cancer and could therefore help identify tumors with aggressive potential.

Original languageEnglish
Pages (from-to)11-15
Number of pages5
JournalBreast Cancer
Volume19
Issue number1
DOIs
Publication statusPublished - Jan 1 2012

Fingerprint

Triple Negative Breast Neoplasms
Anti-Idiotypic Antibodies
Serum
Neoplasms
Breast Neoplasms
Incidence

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology (medical)

Cite this

Nozoe, T., Mori, E., Kono, M., Iguchi, T., Maeda, T., Matsukuma, A., & Ezaki, T. (2012). Serum appearance of anti-p53 antibody in triple negative breast cancer. Breast Cancer, 19(1), 11-15. https://doi.org/10.1007/s12282-010-0244-3

Serum appearance of anti-p53 antibody in triple negative breast cancer. / Nozoe, Tadahiro; Mori, Emiko; Kono, Mayuko; Iguchi, Tomohiro; Maeda, Takashi; Matsukuma, Akito; Ezaki, Takahiro.

In: Breast Cancer, Vol. 19, No. 1, 01.01.2012, p. 11-15.

Research output: Contribution to journalArticle

Nozoe, T, Mori, E, Kono, M, Iguchi, T, Maeda, T, Matsukuma, A & Ezaki, T 2012, 'Serum appearance of anti-p53 antibody in triple negative breast cancer', Breast Cancer, vol. 19, no. 1, pp. 11-15. https://doi.org/10.1007/s12282-010-0244-3
Nozoe T, Mori E, Kono M, Iguchi T, Maeda T, Matsukuma A et al. Serum appearance of anti-p53 antibody in triple negative breast cancer. Breast Cancer. 2012 Jan 1;19(1):11-15. https://doi.org/10.1007/s12282-010-0244-3
Nozoe, Tadahiro ; Mori, Emiko ; Kono, Mayuko ; Iguchi, Tomohiro ; Maeda, Takashi ; Matsukuma, Akito ; Ezaki, Takahiro. / Serum appearance of anti-p53 antibody in triple negative breast cancer. In: Breast Cancer. 2012 ; Vol. 19, No. 1. pp. 11-15.
@article{dc6b75a783924cc78a04e86d12c4acba,
title = "Serum appearance of anti-p53 antibody in triple negative breast cancer",
abstract = "Background: Significance of serum appearance of anti-p53 antibody in breast cancer has not been discussed fully. Methods: The relationship between serum appearance of anti-p53 antibody and the clinicopathological features was investigated on the basis of the data of 42 women with breast cancer who had been treated with surgical resection. Results: The proportion of tumors with histological grade 3 was significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.020). The proportion of triple negative tumors was also significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.003). Conclusions: Preoperative appearance of anti-p53 antibody in sera can be correlated with the incidence of triple negative breast cancer and could therefore help identify tumors with aggressive potential.",
author = "Tadahiro Nozoe and Emiko Mori and Mayuko Kono and Tomohiro Iguchi and Takashi Maeda and Akito Matsukuma and Takahiro Ezaki",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/s12282-010-0244-3",
language = "English",
volume = "19",
pages = "11--15",
journal = "Breast Cancer",
issn = "1340-6868",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Serum appearance of anti-p53 antibody in triple negative breast cancer

AU - Nozoe, Tadahiro

AU - Mori, Emiko

AU - Kono, Mayuko

AU - Iguchi, Tomohiro

AU - Maeda, Takashi

AU - Matsukuma, Akito

AU - Ezaki, Takahiro

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background: Significance of serum appearance of anti-p53 antibody in breast cancer has not been discussed fully. Methods: The relationship between serum appearance of anti-p53 antibody and the clinicopathological features was investigated on the basis of the data of 42 women with breast cancer who had been treated with surgical resection. Results: The proportion of tumors with histological grade 3 was significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.020). The proportion of triple negative tumors was also significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.003). Conclusions: Preoperative appearance of anti-p53 antibody in sera can be correlated with the incidence of triple negative breast cancer and could therefore help identify tumors with aggressive potential.

AB - Background: Significance of serum appearance of anti-p53 antibody in breast cancer has not been discussed fully. Methods: The relationship between serum appearance of anti-p53 antibody and the clinicopathological features was investigated on the basis of the data of 42 women with breast cancer who had been treated with surgical resection. Results: The proportion of tumors with histological grade 3 was significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.020). The proportion of triple negative tumors was also significantly higher among tumors with serum appearance of anti-p53 antibody (P = 0.003). Conclusions: Preoperative appearance of anti-p53 antibody in sera can be correlated with the incidence of triple negative breast cancer and could therefore help identify tumors with aggressive potential.

UR - http://www.scopus.com/inward/record.url?scp=84859789691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859789691&partnerID=8YFLogxK

U2 - 10.1007/s12282-010-0244-3

DO - 10.1007/s12282-010-0244-3

M3 - Article

VL - 19

SP - 11

EP - 15

JO - Breast Cancer

JF - Breast Cancer

SN - 1340-6868

IS - 1

ER -